Small batch pharmaceutical manufacturing, from prototype to the patient.
Medicine for the Future Today
Our steps to commercial reality
STEPS of process development and scale-up to formulation development and analytical testing, TRC works to optimize testing methods to characterize your drug product.
Scalable formulations for your prototype and solidify your analytical test methods. Work with our team and leverage:
Decades of experience working specifically with lipid-based solutions
Advanced analytical testing equipment
A smooth transition from preclinical development to process scale up, clinical batch and cGMP manufacturing
Clinical Supply
From batches of less than 100 to batches of 10,000, we have the capability, speed, and accuracy to create your next major drug product success.
Commercial Contract Manufacturing
Attention to detail, our team works diligently to complete your commercial manufacturing goal. Our wide range of sterile products and specialization in complex biological and liposomal formulations TRC@PG Quality.
The Purecell Pipeline
Pre-clinical studies
New treatments prior to medical of veterinary use are extensively tested in laboratory trials to ensure that they are safe and do not have any unexpected side effects.
Phase 2 clinical trials
When a drug is found to be safe, it will be trialled in small numbers of people with the disease it is intended to treat. In general, these studies run for a short period of time and their main purpose is to test that the drug is safe, and work out what dose of the drug should be given.
Phase 3 clinical trials
Once a drug has been found to be safe and the best dose to be used has been decided, a Phase 3 study will be performed. These studies often involve a larger number of patients and run for a longer period of time. Again, these trials include a group of people taking a placebo. These trials are intended to test whether the drug actually works, and whether it has any side effects from more long-term use.
